Until prospective randomized clinical data accrue and mature, this controversial issue will continue to suffer from overinterpretation of inadequate supporting data.
Vivek Verma, MD
Advertisement
Articles by Vivek Verma, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Dato-DXd for Metastatic Triple-Negative Breast Cancer
2
Data Readouts to Watch at the 2026 ASCO Annual Meeting
3
Osteosarcoma Drug Earns Rare Pediatric Disease, Orphan Drug Designations
4
Alpha DaRT Elicits 100% Local Disease Control in Pancreatic Cancer
5